Latest news with #MartinBurke
The Herald Scotland
a day ago
- The Herald Scotland
This is where Holywood star Grace Kelly stayed in Dublin
SLEEPING MATTERS The Martin Burke suite door opens onto a hall, and I walk into a bright room where the sun beams through a large window. The view of St Stephen's Green is stunning. In front of me is a chaise longue and coffee table with books, bottles of water and some luxury Irish chocolates. The bedroom provides 300-thread Egyptian cotton bedding. A power shower decorated in marble is the ideal way to recover from an early flight. Comfortable robes and slippers are also provided. The hotel features a variety of rooms, all with style and character. NICE TOUCH The Horseshoe Bar is the ideal place to start or finish a night in Dublin with one of their classic cocktails. The friendly barman is happy to freestyle and chat through several options. The Horseshoe is frequented by politicians and cultural figures who stop by for a quiet drink. The film-noir lighting, red walls and brass-trimmed curved bar all add to the low-key atmosphere. Upstairs 1824 displays a variety of Irish figures in a mythological setting featured on mural panels painted by artist Paul Slater. Every choice of late-night tipple you can imagine is on display behind the bar in rich wood panelling. Even better is that both of these magnificent bars are on site. FOOD FOR THOUGHT Sunday evening in the Saddle Room was a relaxing and enjoyable experience, I was well looked after by the staff on a warm, quiet evening with a view. I opted for Bantry Bay scallops for the starter and a fillet of Black Angus beef. The sommelier was happy to answer questions and provided the perfect red wine. Another excellent choice, a two-minute walk away, is Hugo's. The turquoise blue outside decor with gold lettering is an iconic Dublin landmark. It's like entering into another magical world brimming with atmosphere. The Guinness & black treacle bread and dressed West Cork crab are a hunger-quenching start to the evening. Murphy is passionate about local produce, and the Andarl Farm pork chop was a mouth-watering highlight. DRINK IN THE SIGHTS Glasnevin is Ireland's National Cemetery. I was given a tour that included fascinating stories from the world of sport, art and politics. Among them was Manchester United player Billy (Liam) Whelan, who was killed in the Munich Air Disaster in 1958, musician Luke Kelly from The Dubliners and writer Brendan Behan. A short walk from Behan's grave is a pub appropriately known as The Gravediggers, also known as John Kavanagh's, built into the cemetery walls. It's known to serve the best pint of Guinness in Ireland. GETTING THERE Direct access to Dublin is available from airports across Scotland. DETAILS Rates begin at £523. For more information
Associated Press
24-03-2025
- Health
- Associated Press
AtaCor Medical Enrolls First Patients in its ASCEND EV Clinical Study
The novel design of AtaCor's EV-ICD Atala™ lead aims to provide reliable sensing, antitachycardia pacing (ATP), and shock therapies through an extravascular approach Initial cases demonstrated successful sensing and defibrillation of induced ventricular fibrillation with the Atala™ lead, across a range of commercially available ICDs Study marks the first permanent implantation of the company's EV-ICD Lead System for the treatment of life-threatening ventricular tachyarrhythmias SAN CLEMENTE, Calif., March 24, 2025 /PRNewswire/ -- AtaCor Medical, Inc., a privately-held medical device company focused on transforming cardiac rhythm management, announced today that it has initiated its ASCEND EV study. The prospective, non-randomized international study aims to evaluate the safety and performance of AtaCor's all-in-one Extravascular Implantable Cardioverter Defibrillator (EV-ICD) Lead System in combination with leading commercially available transvenous ICDs. The initial cases were performed at a single clinical site and demonstrated successful sensing and defibrillation of induced ventricular fibrillation using the Atala™ lead in connection to a range of commercially available ICDs. 'Extravascular solutions allow physicians to deliver critical therapy while maintaining the integrity of the heart,' commented Dr. Shephal Doshi, ASCEND EV study investigator and Executive Director of the Heart and Vascular Institute, Providence Saint John's Health Center & Cardiac Electrophysiology at the Pacific Heart Institute/Cedars Sinai. 'AtaCor's innovative design is an exciting advancement with the potential to elevate the standard for cardiac rhythm management. I am impressed by these first cases, and I look forward to following the clinical progress as more patients are treated.' The AtaCor EV-ICD Lead System aims to deliver life-saving ICD benefits without the complications associated with transvenous leads or the pacing discomfort associated with other extravascular ICD systems. The all-in-one system facilitates both antitachycardia pacing (ATP) and shock delivery from a single lead and with one procedure – all without entering the heart or vascular system. Implanted via a streamlined parasternal approach, the system is designed for compatibility with commercially available transvenous ICDs and will accommodate either a lateral or left-pectoral pulse generator pocket placement. 'AtaCor is committed to revolutionizing cardiac rhythm management and protecting the integrity of the heart for future cardiac care needs. We are thrilled to have successfully completed this first round of cases, a critical step towards validating AtaCor's Atala™ lead,' stated Dr. Martin Burke, Chief Medical Officer of AtaCor Medical. 'Thank you to the entire AtaCor team for their tireless efforts and our physician partners for their invaluable expertise to achieve this important milestone. We look forward to adding additional clinical sites in the coming months.' The AtaCor EV-ICD Lead System is under development exclusively for investigational use and is not approved for sale in any geography. ABOUT ATACOR MEDICAL
Yahoo
24-03-2025
- Business
- Yahoo
MS Amlin binds reinsurance scheme for SMEs in Ukraine
MS Amlin has bound a reinsurance scheme, developed in collaboration with the European Bank for Reconstruction and Development (EBRD) and Aon, to support small and medium-sized enterprises (SMEs) in Ukraine. This initiative will provide up to €1bn in annual cover for inland cargo and transport. MS Amlin has pledged an initial reinsurance capacity of €80m, which may increase to €110m over a five-year period. This capacity will support war risk policies underwritten by INGO, Colonnade and UNIQA. The EBRD's guarantee enables MS Amlin to transfer this exposure off its balance sheet. The nature of these short-term policies facilitates the recycling of capital, potentially allowing the facility to extend coverage well beyond the guaranteed amount. It is estimated that the facility could cover up to €1bn worth of goods and vehicles each year, culminating in €5bn over the duration of the scheme. The initiative has garnered initial backing from France, the UK, Norway and the Taiwan Business-EBRD Technical Cooperation Fund. Both the EU and Switzerland have committed to offering contributions, with additional donor support expected to increase the EBRD guarantee gradually. MS Amlin chief underwriting officer Martin Burke said: 'Expanding access to insurance is critical for supporting Ukraine's SMEs and overall economy. By addressing a gap in reinsurance, this scheme will help boost business confidence, protect supply chains and drive economic growth. 'The facility highlights how specialist insurers can unlock investment in high-risk regions and demonstrates the key role of public-private partnerships in rebuilding Ukraine. By leading the way on this facility, we aim to attract additional market capacity, vital for Ukraine's long-term reconstruction and recovery.' In December 2024, the EBRD and Aon introduced the €110m Ukraine Recovery and Reconstruction Guarantee Facility. "MS Amlin binds reinsurance scheme for SMEs in Ukraine " was originally created and published by Life Insurance International, a GlobalData owned brand. The information on this site has been included in good faith for general informational purposes only. It is not intended to amount to advice on which you should rely, and we give no representation, warranty or guarantee, whether express or implied as to its accuracy or completeness. You must obtain professional or specialist advice before taking, or refraining from, any action on the basis of the content on our site. Sign in to access your portfolio
